"Designing Growth Strategies is in our DNA"

Metal Implants and Medical Alloys Market Size, Share and Industry Analysis By Material (Titanium, Stainless Steel, Cobalt-Chromium, and Others), By Application (Orthopedic Surgery {Joint Reconstruction Devices [Knee Reconstruction Devices, Hip Reconstruction Devices, Shoulder Reconstruction Devices, and Others], Spinal Implants [Spinal Fusion Devices, Spinal Decompression Devices, and Others], and Trauma Fixation Devices [Metal Plates & Screws, Pins, and Others]}, Cardiovascular {Implantable Cardiac By End-user (Hospitals & ASCs, Specialty Clinics, and Others), and Regional Forecast, 2026-2034

Region : Global | Report ID: FBI115609 | Status : Ongoing

 

KEY MARKET INSIGHTS

The global metal implants and medical alloys market is experiencing significant growth, primarily driven by the increasing prevalence of chronic conditions, such as cardiovascular diseases. This is expected to drive the need for surgeries, ultimately increasing the utilization of metal implants and medical alloys.

  • For instance, according to data published by the Centers for Disease Control and Prevention (CDC) in October 2024, around 1 in 20 adults aged 20 and older had coronary artery disease in 2024.

Additionally, key players are expanding their portfolios of implants and alloys to meet the growing global demand for an increasing number of medical procedures.

Metal Implants and Medical Alloys Market Driver

Rising Number of Surgeries to Fuel Market Growth

Over the past few years, there has been a growing number of key surgeries such as joint replacements, spinal fixations, dental implants, and other metal-implant procedures due to the increasing prevalence of musculoskeletal disorders, trauma, and chronic diseases. The increasing demand for surgery is driving the global utilization of metal implants and medical alloys, which is expected to drive market growth in the coming years.

  • For instance, in November 2024, the American Joint Replacement Registry (AJRR) surpassed 4.0 million knee and hip arthroplasty procedures.

Download Free sample to learn more about this report.

According to data published by Eurostat in October 2023, around 1.1 million transluminal coronary angioplasty procedures were performed across 25 European countries in 2021. Croatia had the highest rate at 553 procedures per 100,000 people, followed by Germany (390), Latvia (328), Austria (324), and Bulgaria (303).

Metal Implants and Medical Alloys Market Restraint

High Cost of Implantable Metal Implants May Hinder Market Growth

The high cost of implantable metal alloys and complex manufacturing processes, combined with stringent regulatory approvals and long product development cycles, is expected to hinder their widespread adoption globally. Additionally, these cost barriers are expected to deter new entrants or smaller players from expanding rapidly, further hindering market expansion.

Metal Implants and Medical Alloys Market Opportunity

Development of New Alloy Technologies and Manufacturing Methods to Offer Lucrative Opportunities

Recently, key players have been focusing on the development of new alloy technologies and manufacturing methods, including shape-memory alloys, bioresorbable metal implants, patient-specific 3D-printed implants, and the application of artificial intelligence to manufacture new alloys. These innovations are expected to open up new applications, such as minimally invasive surgery and custom dental solutions, thereby enhancing the surgical scenario.

  • For instance, in March 2025, researchers at Johns Hopkins utilized artificial intelligence to develop faster and more effective methods for manufacturing titanium alloy components, thereby enhancing their mechanical properties.

Segmentation

By Material

By Application

By End-user

By Geography

  • Titanium
  • Stainless Steel
  • Cobalt-Chromium
  • Others
  • Orthopedic Surgery

o    Joint Reconstruction Devices

  • Knee Reconstruction Devices
  • Hip Reconstruction Devices
  • Shoulder Reconstruction Devices
  • Others

o    Spinal Implants

  • Spinal Fusion Devices
  • Spinal Decompression Devices
  • Others

o    Trauma Fixation Devices

  • Metal Plates & Screws
  • Pins
  • Others
  • Cardiovascular

o    Implantable Cardiac Defibrillators (ICDs)

o    Implantable Cardiac Pacemakers (ICPs)

o    Mechanical Heart Valves

o    Stents

o    Others

  • Dental

o    Dental Implants

o    Orthodontic Appliances

o    Metal Bridges & Crowns

o    Others

  • Neurological
  • Others
  • Hospitals & ASCs
  • Specialty Clinics
  • Others

·      North America (U.S. and Canada)

·      Europe (U.K., Germany, France, Spain, Italy, Scandinavia, and the Rest of Europe)

·      Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)

·      Latin America (Brazil, Mexico, and the Rest of Latin America)

·      Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)

Key Insights

The report covers the following key insights:

  • Prevalence/Incidence of Key Diseases, By Key Countries/ Region, 2024
  • Number of Key Procedures, By Key Countries/ Region, 2024
  • Advancements in Metal Implants and Medical Alloys
  • Key Industry Developments - (Mergers, Acquisitions & Partnerships, and Others)

Analysis by Material

Based on material, the market is subdivided into titanium, stainless steel, cobalt-chromium, and others.

The titanium segment is expected to account for the largest market share during the forecast period. The segment’s growth is mainly attributed to its high strength-to-weight ratio, corrosion resistance, osteointegration, and MRI compatibility. This has made titanium a preferred choice across orthopedic, dental, and cardiovascular surgeries.

  • For instance, according to data published by the National Center for Biotechnology Information (NCBI) in July 2023, titanium is widely used in orthopedic implants, with most femoral stems in total hip replacements being made from titanium alloy.

Analysis by Application

The market is divided into orthopedic surgery, cardiovascular, dental, neurological, and others by application.

The orthopedic surgery segment is expected to hold a major share during the forecast period. There is a high volume of joint reconstruction, trauma fixation, and spine procedures driven by the rise in the global aging population and musculoskeletal disease burden. This is expected to drive the segment’s growth during the forecast period.

  • For instance, as per data from the American College of Rheumatology, around 790,000 total knee replacements and 544,000 hip replacement surgeries are performed annually in the U.S.

Analysis by End-user

By end-user, the market is categorized into hospitals & ASCs, specialty clinics, and others.

The hospitals & ASCs segment is expected to hold the largest market share in 2024.  The majority of surgeries are being performed in hospitals and ambulatory surgery centers (ASCs), which is driving the utilization of metal implants and medical alloys in these settings. Such a scenario is anticipated to fuel the segment’s growth over the forthcoming years.

  • For instance

Regional Analysis

Request for Customization   to gain extensive market insights.

Based on region, the market has been analyzed across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America held the largest global metal implants and medical alloys market share in 2024. The growth is attributed to the well-established infrastructure in the region, which is supporting the large number of surgical volumes performed. Moreover, the increasing number of ASCs in the region is also expected to contribute to the number of orthopedic and other surgeries performed, thereby driving metal implants adoption.

  • For instance, as of March 2025, the Ambulatory Surgery Center Association (ASCA) reported that there were over 6,500 Medicare-certified ASCs in the U.S.

Asia Pacific is expected to grow at the highest CAGR during the analysis period. The growth is attributed to the high prevalence of dental diseases, trauma and sports injuries, and musculoskeletal disorders, which are driving the surgical volume in the region. This is encouraging key players to expand the supply of metal implants and medical alloys in the region.

Key Players Covered

The global metal implants and medical alloys market is led by key players such as Carpenter Technology Corporation (CRS Holdings, LLC), DSM-Firmenich (Royal DSM), Johnson Matthey, and ATI. These companies have a significant focus on increasing their product supply and global presence to enhance their competitive position.

The report includes the profiles of the following key players:

  • Carpenter Technology Corporation (CRS Holdings, LLC) (U.S.)
  • DSM-Firmenich (Royal DSM) (Netherlands)
  • Johnson Matthey (U.K.)
  • ATI (U.S.)
  • AMETEK Inc (U.S.)
  • Aperam S.A. (Luxembourg)
  • QuesTek Innovations LLC (U.S.)
  • Fort Wayne Metals Research Products, LLC (U.S.)
  • Ulbrich Stainless Steels & Special Metals Inc. (U.S.)

Key Industry Developments

  • April 2025: restor3d secured USD 38.0 million in funding to broaden its 3D-printed orthopedic implant portfolio. The investment will drive the introduction of four new osseointegrative systems: the Veritas Reverse Shoulder, Total Identity 3DP Porous Cementless Knee, Kinos Modular Stem Total Ankle, and Velora 3DP Porous Hip Cup.
  • September 2024: Maxx Orthopedics obtained FDA 510(k) clearance for its Fresedom Titan PCK Revision Knee System, which incorporates titanium stems and a TiNbN coating.


  • Ongoing
  • 2025
  • 2021-2024
Download Free Sample

    man icon
    Mail icon

Get 20% Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann